VAERS reports by lot

Merck HPV lot M024261: VAERS reports

37 VAERS reports list lot M024261 as a Merck HPV vaccine, received between 2016-10-13 and 2018-12-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
11%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1534%
Neurological818%
Injection-site / Local reaction818%
Gastrointestinal511%
Musculoskeletal49%
Allergic / Anaphylactic25%
Cardiac / Cardiovascular12%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas8
New Jersey2
Virginia2
Rhode Island2
Pennsylvania2
Colorado2
Alaska2
Indiana1
Iowa1
Illinois1
Oklahoma1
New Mexico1

Reports by month received

2016-104
2016-111
2016-121
2017-017
2017-028
2017-036
2017-042
2017-051
2017-082
2018-031
2018-081
2018-101
2018-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.